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Abstract 
The present study was designed to investigate the viability of neurofeedback training which 
entails the acquisition of effortful learning skills to gain volitional control on electrocortical activity 
in order to ameliorate executive function of schizophrenic patients. In this pre-test post-test design 
30 schizophrenic male inpatients were selected out of which fifteen were trained to inhibit delta and 
theta at frontal cortex and reward SMR at vertex. Wisconsin Card Sorting Test was administered 
prior and after the training stage. Descriptive methods were used and P-value <0.05 was considered 
statistically significant. The results revealed significant improvement in executive functioning 
measures in experimental group relative to the control group. Our finding suggests that being the 
prime feature of the disorder does not necessarily imply intractability.  It was once believed that 
schizophrenic patients could not learn to modify their bioelectrical functioning while the findings of 
the current research prompted a re-thinking. 
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Introduction 
With its annihilating effect, schizophrenia has always been regarded as the most devitalizing 
psychiatric illness (Clark, 2001). Affecting about 1% of the population (Tandon, Nasrallah & 
Keshavan, 2009), this variegated disease, enervates the caregivers(Clark, 2001)  and leaves the 
clinicians prostrated with its chronic course and deteriorating feature as is evident by Kraepelin’s 
nomenclature (1919) “dementia praecox”. The disease process results in aberrant clinical 
presentations such as positive and negative clusters, as well as cognitive dysfunctions (Tandon, 
Nasrallah&Keshavan, 2009). Kraepelin acknowledged the latter one as the uncontested salient 
features of the disorder. Innumerable numbers of evidence converge to demonstrate that cognitive 
impairments are present in this disorder (Klonoff et al, 1970; Saykin et al, 1991; 
Heinrichs&Zakzanis, 1998; Mohamed, O’Leary & Andreasen, 1999; Heaton et al, 2001; 
Nuechterlein, 2004). Being detectable even in premorbid level of disease (Fuller et al, 2002) first-
onset schizophrenia and prior to the administration of antipsychotics (Saykin, 1994), this 
phenomena correspondingly increases the imperative to devise an optimum treatment. Among the 
extensive arrays of cognitive domains being studied, executive function, the term under the shadow 
of which series of cognitive abilities such as goal-orientation, planning (Velligan& Bow-Thomas, 
1999), inhibition (Smith &Jonides, 1999) and cognitive flexibility (McCabe et al, 2010) are 
included, continues to be the crux of treatment. 
Despite extensive endeavors to alleviate cognitive decays, dearth of investigations has taken 
the advantage of utilizing a technique placed between behavioral and physiological realms in the 
rehabilitation of these decrements. In prioritizing the treatment paradigms, pharmacotherapy has 
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always been the benchmark of treatment (Sadock&Sadock, 2007); however,  marginal effects of 
conventional antipsychotics (Medalia et al., 1988; Spohn&Strauss, 1989), side effect of second 
generation (Sadock&Sadock, 2007) and even modest benefits of other medication options in 
conjunction with antipsychotics such as bupropion (Rezaee,Masafi, Mohamadreza&Akbarpour, 
2012),lack of insight and therefore lack of compliance (Buckley et al, 2007) prompt the clinicians to 
consider alternative non-pharmaceutical modalities such as neurofeedback.Based on the behavioral 
approach and operant conditioning paradigm, NF is termed as “internal cerebral exercise” (Tansey, 
1983). Benefiting from shaping procedure (Leslie, 2011), the ultimate goal of this technique as 
Vernon (2005) aptly stated is the “re-creation of cortical activity patterns”. This appealing strategy, 
not only heightens awareness  by means of eliciting desirable brain activity and inhibiting abnormal 
electrocortical  activity (Kouijzer et al, 2009), but also reinforces voluntary control on 
electrophysiological components. There has been reports about beneficial effects of NF on an 
assortment of psychiatric illnesses such as attention deficits (Lubar&Lubar, 1984), seizure 
(sterman& Friar, 1972) autism (Kouijzer et al, 2009), depression (Saxby &Peniston, 1995), and even 
schizophrenia. However, relevant attempts mostly evolve around the symptomatology of this 
disorder.  
 In the most preliminary study Schneider et al (1992) ameliorated attention breakdown of 
schizophrenics through regulating the slow cortical potentials.  
By adopting the model of functional hemispheric imbalance, Gruzelier et al (1999) trained 
16 patients to shift negativity in the opposite directions with respect to the symptom pictures they 
exhibited. In an in-depth case study, Schummer (2008) uncovered favorable effects of NF in a 
protracted process. Ruiz (2011) trained nine schizophrenic patients to volitionally up- and down-
regulate anterior insular cortex activity in an attempt to improve face emotion recognition. Bolea’s 
report (2010) provides suggestive evidence that alpha enhancement and inhibiting delta and fast beta 
reduce some schizophrenics’ disturbances.Surmeliet al (2012) further showed significant 
improvement of clinical symptoms and attention with personalized protocols after NF. On the 
framework of previous reports and observations aboutneuropsychophysiological features and 
consequent neurobehavioral dysfunctions in schizophrenia, Rocha et al (2009) offered new 
directions for protocol designation. The findings of these authors in 2011 in an experimental setting, 
yield measurable cognitive benefits after NFT in 3 schizophrenic patients who were trained to 
inhibit theta and high beta while rewarding SMR. All in all, the work of Rocha (2011) and Surmeli 
could be regarded as the only studies of NFT in cognition spheres of schizophrenics. Given the 
scarcity of results involving the effects of NF on cognitive decrements of schizophrenic patients and 
exiguousness of data on the effects of NF on executive dysfunctions, more scientific exploration is 
warranted as a laboratory experiment. The present study is conducted to fulfill this need. 
 
Materials and Methods 
The study recruited 30 institutionalized male inpatients ranged in age 18-60 (mean 
age=41.60 years)(Table 1). Establishment of diagnoses was based on semi-structured interviews 
which were conducted by an expert psychiatrist according to the criteria of fourth edition of the 
diagnostic and statistical manual of mental disorders (DSM-IV-TR) (Table 2). Informed consent was 
obtained after full explanation of purpose and procedure of the study. Positive and Negative 
Syndrome Scale was used for the sake of psychopathological evaluation as well as ruling out 
depression. Inclusion criteria are as follows: (1) Diagnosis of mental retardation (2) concurrent 
substance abuse (3) neurological damage (4) comorbid psychiatric illnesses and (5) experience of 
electroconvulsive therapy 3 months prior to the experiment. Patients were also excluded if they were 
on clozapine and olanzapine medication since their influence on EEG parameters and cognitive 
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functions have been previously reported.(Centorrino, 2002; Pillmann, 2000).Subjects were allocated 
randomly into two groups.The study consisted of a 4-month successive training period. All patients 
were on antipsychotic medication during training course. The experimental group completed 30 
sessions, each lasting approximately 50-minutes with 2 intervals of 5 minutes in between. In a 
complete sham debriefing session, patients were acclimatized with the experimental setting. The 
experiment was performed in a sound-attenuated, electrical shield room to circumvent any artifact. 
NFT was administered using NEXUS 4 channel device. Resting baseline was carried out in 2 
minutes with eyes open. They were instructed to reduce muscle activity and control eye blinks. The 
amplitudes were calculated in delta (0–4 Hz), theta (4–7 Hz) and SMR (12-15 Hz) bands for each 
participant. EEG was recorded over right hemisphere (F4) with reference placed on the right earlobe 
and ground electrode on the left earlobe throughout the first 10 sessions. During the middle 10 
sessions, F3 (left hemisphere) was selected with symmetrical pattern. In the course of the last 10 
sessions data were acquired via electrode situated at Cz with reference on the left ear and ground on 
the right ear. Manual threshold setting was used. Feedback displays contained different animation 
with melodious sounds accompaniment. Experimental group were trained to inhibit delta and theta 
at F3 and F4 and reinforce SMR at Cz while simultaneously inhibited theta. 
 
Table 1. Demographic characteristics of schizophrenia patients 
         Mean(SD) 
 Experimental group (n=15) Control group (n=15) 
Age 42.06 (2.36) 41.13 (2.86) 
Education 11.26 (0.529) 11.06 (0.520) 
Age at onset 25.26 (1.37)  25.40 (1.58) 
Duration of illness 16.80 (2.14) 15.73 (2.71) 
 
Table 2. Statistics of assessments with clinical scale (PANSS) 
 Mean(SD) 




PANSS score 38.26 (2.08) 39.40 (2.63) 
Panss negative subscale 5.53 (0.893) 4.60 (0.681) 
Panss positive subscale 10 (1.27) 11.33(1.25) 
 
Table 3. Normality of distribution (Shapiro-wilks) 
Control Experimental   
Sig F Sig value F 
.114 .805 .051 .748 Completed category 
.052 .857 .558 .952 Perseverative responses 
.061 .868 .062 .888 Correct responses 
.061 .868 .062 .888 Errors 
.089 .596 .151 .728 Percentage of conceptual level 
.171 .749 .084 .859 Failure to maintain a set 
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Statistical analysis 
In this pre-test post-test design, multivariate analysis of covariance (MANCOVA) was used 
with pre-test as the between-group factor for controlling the test-wise effects, and six EF composite 
function scores as the dependent variables. Statistical analyses were performed using SPSS (version 
21). Shapiro-Wilks test was applied to test for the normality of the distribution of the data (Table 3).  
The significance level was set at two-tailed p<0.05. Table 4 displays thatLevene’s Test of 
homogeneity of variances is non-significant (the group variance is equal), therefore it is inferred that 
the assumption of homogeneity of regression  is met allowing for the administration of MANCOVA. 
Statistical analysis of experimental and control group patients performance are presented in Table 6. 
 
Table 4.Equality of Variances. (Leven’s Test) 
Sig value F  
.252 1.403 Completed category 
.213 1.896 Perseverative responses 
.679 .175 Correct responses 
.952 .004 Errors 
.091 3.060 Percentage of conceptual level 
.526 .413 Failure to maintain a set 
 
Results  
As table 5 indicates, the control group did not appear to show significant changes in post-test 
on any of the EF measures. By contrast, in table 6, scores changed significantly in the experimental 
group for the number of categories attained (f = 11.986, df = 1, p <0.02). Also, Scores declined 
significantly for number of preservative errors(f = 8.197, df = 1, p <.008). The experimental group 
also improved significantly more than the control group in terms of correct responses (f = 6.294, df 
= 1, p <.018) indicating heightened accuracy after treatment. Receivers responded to WCST with 
significantly less errors compared to non-receivers (f =8.164, df = 1, p <.008). Percentage of 
conceptual level revealed the improved changes in patients conceptualization during test 
performance (f =4.801, df = 1, p <.037).Comparisons in terms of failure to maintain a set showed an 
additional group difference between receivers and non-receivers implying the effectiveness of NF 
on WCST performance. The experimental group showed the most improvement on failure to 
maintain a set and completed category measures regarding the Eta squares (30%, 77%). 
 
Table 5.Performance of experimental and control group on WCST. 
Control  Experimental  
Post- test Pre-test Post- test Pre-test 
SD Mean SD  Mean SD  Mean  SD Mean 
.81 1.66 .94 1.80 1.67 3.33 0.89 1.66 Completed category 
7.4 14.6 8.0 16. 2.8 8.8 4.6 14.0 Perseverative responses 
4.98 27.6 5.0 27. 5.05 32.2 5.1 26.4 Correct responses 
5.0 31.8 5.01 33.0 4.09 27.0 5.1 33.6 Errors 
38.3 22.40 33.4 20.1 44.7 55.73 35.61 24.7 Percentage of conceptual 
level 
3.4 11.8 5.3 10.4 1.8 1.93 2.13 13.4 Failure to maintain a set 
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sig F Mean 
square 
Df Sum of 
squares 
 
.916 .300 .002 11.986 20.833 1 20.833 Completed 
category 
.789 .226 .008 8.197 258.133 1 258.133 Perseverative 
responses 
.678 .184 .018 6.294 158.700 1 158.700 Correct 
responses 
.788 .226 .008 8.164 172.800 1 172.800 Errors 
.562 .146 .037 4.801 8333.333 1 8333.333 Percentage of 
conceptual 
level 
1.000 .775 .000 96.526 740.033 1 740.033 Failure to 
maintain a set 
 
Discussion 
Although the neurophysiological mechanisms being affected by this technique need full 
elucidation, it is tempting to surmise about such mechanisms contributing to our results. The 
underlying rational of inhibiting delta at Broadman area 46 and 9 (right and left dorsolateral 
prefrontal cortex) is the findings extracted from studies suggesting that functional EEG anomalies in 
schizophrenia are predominantly polarized around frontal areas (Mukundan, 1986;Schellenberg et 
al, 1990;Saletu et al, 1990; Takeuchi et al., 1995; Knott et al, 2001). Notable reliance of executive 
variables such as inhibition (Diamond, 1990a) or regulation of behavior (Braver, Barch&cohen, 
1999) on DLPFC has been documented. Abnormal perfusion termed “hypofrontality” has been 
observed in prefrontal cortex during performance of the WCST (Weinberger, Berman &Zec, 1986). 
Frontal hypofusion is explained by delta excess (Miyauchi et al, 1990; Morihisa, Duffy & Wyatt, 
1983) of which increase has been reported at F3 and F4 leads (Begic, 2011). We hypothesize that 
the observed viability of this protocol, chiefly relies on the improved perfusion to DLPFC. In other 
words, down-regulation of delta power may have modulated DLPFC’s functionality believed to 
support cognitive control (Cohen, Braver, Oreilly, 1996), hence the improved performance in 
WCST. 
 Apart from that, we intended to decrease theta power at Cz. Medial prefrontal brain regions 
including the anterior cingulate cortex (ACC) has been postulated to be the locus of theta generation 
(Tsujimoto, Shimazu, &Isomura, 2006). The pivotal role of different parts of Acc in theta generation 
in central brain regions has also been reported by Luu and Tucker (2001). There exists clear inverse 
correlation between the activation of this area and theta production .The observed excess of theta 
activity in schizophrenia (Sponheim, 1994) on one hand  and abnormal Acc function with its 
contribution to cognitive control abilities  and cognitive conflict tasks(Bush, Luu, & Posner, 2000; 
Henderson et al, 2006), on the other hand, led to our speculation that NFT aiming at reducing  theta 
power at vertex may have given a rise to improved  activation of Acc areas believed to be involved 
in regulating cognitive functions. This might have culminated to better task performance in its own 
right.  This is in harmony with predictions byKouijzer (2008) who declared that better performance 
of executive requiring mechanisms originates from improved activation of Acc and down-regulation  
of theta activities. 
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In addition to theta inhibition at Cz, synchronous SMR enhancement was required 
concerning the reported effects of SMR up-training on working memory (Vernon et al, 2003), its 
relation to inhibition (Budzinsky, 2009), and its impact on attentional states (Kaiser, 2000) as well 
as cortex stabilization (sternman 2000b). Furthermore, SMR reinforcement has been linked to 
reduction of impulsive behavior (Thompson, 1998). . EF has been introduced to have a role in 
integration of temporal times and rendering people to direct behavior in goal directed manner 
(Vaziri, Rezaei&Dolatshahi, 2012).The increased number of categories is a document of patients’ 
improved ability to monitor self, plan and coordinate behavior in a goal-oriented fashion which are 
collectively in contradiction with impulsion. In this context, it is reasonable to assume that SMR 
activity might have led to functional changes of these areas following stimulation. This supposition 
is in broad concordance with researchers’ speculation about the impact of manipulation of the 
brain’s neural processes following SMR training (Finley et al, 1975; Lubar&Bahler, 1976; Sterman, 
1977). 
Deficiency in inhibition which manifests itself in failure to suppress the proneness to react 
(milner, 1963) is conceptually associated to perseverative errors (steinmentz, 2011). Notable 
reduction in the number of perseverations made authors to posit that NFT directly enhanced 
activation of areas governing inhibition. Alternatively, it might have consolidated the network 
included within the areas involved in cognitive control (Cohen et al, 2000) thus, enabled patients to 
inhibit their tendency to respond and reflect on the strategies to adopt in the next classification, 
which may have contributed to improved set-shifting and consequently diminished number of 
perseverations.  
Improved set-shifting skill is also reflected in augmented number of categories. Pantelis et al 
(2009) believe that set shifting requirement is shifting attention across various stimulus dimensions 
considering the feedback received. In set-shifting paradigms, such as WSCT, subjects are required 
to shift attention between different stimulus dimensions on the basis of reinforcing feedback. The 
most likely explanation for the observed improvement may be the already learned strategies. In fact, 
the most basic skill leading to mastery in NF complications is profiting from received feedback. 
Likewise, it seems that task accomplishment in WCST arises from the subjects’ alertness to benefit 
from feedbacks while attempting to sort cards. Given this, we hypothesize that getting familiarized 
with this efficient strategy to regulate self during the training sessions, rendered patients more vigil 
to check errors and monitor self in exposure to feedbacks and as a result adopt novel strategies in the 
new situation (rule change). 
Beside neurophysiological interpretations, it is worth considering self-confidence enhancing 
effects beneath the learning experience. Pharmacothery, despite being invaluable, is not regarded as 
a self-confidence bolsterer. Active participation and engagement in a novel visually absorbing 
training and interactive context in which they are entitled with rights to select the programs may 
have boosted a sense of control for a population who have elapsed great proportion of their lives in a 
rigidly-structured setting. This would mean that NFT aided to challenge the passivity that is a 
characteristic of some negative symptom patients. Moreover, the sense of success gained after 
mastery of games may have led to intrinsic motivation which in turn donates more activation, 
energy and direction to the behavior (Velligan, Kern & Gold, 2006). 
Like several studies, potential limitations make the reader cautious in interpreting the results. 
First, it was not possible to make the study a fully blinded design. Second, small number of subjects 
in each group obviously makes reaching to conclusive results difficult. Third, the insufficient control 
of the contaminating influence of medication on EEG parameters must be considered a 
complication, thus executing a drug -washing procedureremains the domain of future researches. 
Another shortcoming was the inaccessibility to Quantitative electroencephalogram device to 
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measure the distinct individualized EEG patterns. Thus, it is suggested to customize individualized 
treatment protocols in further studies. There is a need for further studies to address other cognitive 
functions. Moreover, suitability of NFT on schizophrenia spectrum disorders, females and other 
subtypes of schizophrenia could be goals for future studies. 
 
Conclusion 
It was once believed that schizophrenic patients cannot learn to modify their bioelectirical 
functioning, thus this may seem a startling claim that schizophrenic patients can learn, however the 
findings of the current research prompt a re-thinking. Not only are these patients able to exert some 
control over their electroencephalographic waves but are also capable to apply these techniques in 
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